The discovery and characterization of a second generation von Willebrand factor (VWF) A-1 domain inhibitory aptamer

被引:0
|
作者
Schaub, R. G. [1 ]
Pendergrast, P. S. [1 ]
McGinness, K. E. [1 ]
Tian, X. [1 ]
机构
[1] Archemix Corp, Res & Dev, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:198 / 198
页数:1
相关论文
共 50 条
  • [1] The Generation of An Aptamer Inhibitor of Murine Von Willebrand Factor (VWF) Mediated Platelet Aggregation.
    Woelfel, Melissa
    De Meyer, Simon
    Wagner, Patricia
    McGinness, Kathleen E.
    Wagner, Denisa D.
    Schaub, Robert
    BLOOD, 2010, 116 (21) : 1749 - 1749
  • [2] The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
    Kovacevic, Katarina D.
    Grafeneder, Jurgen
    Schorgenhofer, Christian
    Gelbenegger, Georg
    Gager, Gloria
    Firbas, Christa
    Quehenberger, Peter
    Jilma-Stohlawetz, Petra
    Bileck, Andrea
    Zhu, Shuhao
    Gilbert, James C.
    Beliveau, Martin
    Jilma, Bernd
    Derhaschnig, Ulla
    HAEMATOLOGICA, 2022, 107 (09) : 2121 - 2132
  • [3] The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer
    Zhu, Shuhao
    Gilbert, James C.
    Hatala, Paul
    Harvey, Warren
    Liang, Zicai
    Gao, Shan
    Kang, Daiwu
    Jilma, Bernd
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (05) : 1113 - 1123
  • [4] Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with Aptamer ARC1172, An Inhibitor of VWF-Platelet Binding
    Huang, Ren-Huai
    Fremont, David
    Tuley, Elodee A.
    Diener, John L.
    Schaub, Robert G.
    Sadler, J. Evan
    BLOOD, 2008, 112 (11) : 101 - 102
  • [5] The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF
    Rosenberg, JB
    Haberichter, SL
    Jozwiak, MA
    Vokac, EA
    Kroner, PA
    Fahs, SA
    Kawai, YK
    Montgomery, RR
    BLOOD, 2002, 100 (05) : 1699 - 1706
  • [6] Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
    Suiter, T. M.
    Mannucci, P. M.
    Kempton, C.
    Laffan, M.
    Romond, E. H.
    Shapiro, A.
    Birschmann, I.
    Ragni, M. V.
    Gill, J. C.
    Yee, T. T.
    Klamroth, R.
    Horling, F. M.
    Reipert, B. M.
    Turecek, P. L.
    Varadi, K.
    Chapman, M.
    Engl, W.
    Wong, W. Y.
    Ewenstein, B. M.
    HAEMOPHILIA, 2012, 18 : 42 - 43
  • [7] A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance.
    Gavazova, S
    Gill, JC
    Scott, JP
    Hillery, CA
    Friedman, KD
    Wetzel, N
    Jozwiak, M
    Haberichter, SL
    Christopherson, P
    Montgomery, RR
    BLOOD, 2002, 100 (11) : 128A - 128A
  • [8] Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease
    Suiter, Tobias M.
    Mannucci, Pier Mannuccio
    Kempton, Christine L.
    Laffan, Michael
    Romond, Edward H.
    Shapiro, Amy D.
    Birschmann, Ingvild
    Ragni, Margaret V.
    Gill, Joan Cox
    Yee, Thynn Thynn
    Klamroth, Robert
    Horling, Frank M.
    Reipert, Birgit M.
    Turecek, Peter L.
    Varadi, Katalin
    Chapman, Miranda
    Engl, Werner
    Wong, Wing Yen
    Ewenstein, Bruce M.
    BLOOD, 2011, 118 (21) : 987 - 988
  • [9] Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF: AG in von willebrand disease
    Suiter, T.
    Mannucci, P. M.
    Kempton, C. L.
    Laffan, M.
    Romond, E. H.
    Shapiro, A. D.
    Birschmann, I
    Ragni, M., V
    Gill, J. C.
    Yee, T. T.
    Klamroth, R.
    Horling, F. M.
    Reipert, B. M.
    Turecek, P. L.
    Varadi, K.
    Chapman, M.
    Engl, W.
    Wong, W. Y.
    Ewenstein, B. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 97 - 98
  • [10] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Haberichter, Sandra L.
    Balistreri, Michael
    Christopherson, Pamela
    Morateck, Patricia
    Gavazova, Stefana
    Bellissimo, Daniel B.
    Manco-Johnson, Marilyn J.
    Gill, Joan Cox
    Montgomery, Robert R.
    BLOOD, 2006, 108 (10) : 3344 - 3351